๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A prognostic-factor risk index in advanced non-small-cell lung cancer treated with cisplatin-containing combination chemotherapy

โœ Scribed by Tetsu Shinkai; Kenji Eguchi; Yasutsuna Sasaki; Tomohide Tamura; Yuichiro Ohe; Akira Kojima; Fumihiro Oshita; Toshimichi Miya; Hiroaki Okamoto; Kazuchiyo Iemura; Nagahiro Saijo

Publisher
Springer
Year
1992
Tongue
English
Weight
654 KB
Volume
30
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Combination chemotherapy with mitomycin-
Combination chemotherapy with mitomycin-C, cisplatin, and vinblastine in the treatment of non-small-cell lung cancer
โœ Niell, Harvey B. ;Griffin, John P. ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 443 KB

The drug combination of mitomycin-C, cisplatin, and vinblastine was administered to 30 patients with stage III non-small-cell lung cancer. All patients had a performance status of 50% or greater, had evaluable disease, and had not received previous chemotherapy. The overall response rate was 37% wit

Infections in patients with non-small-ce
Infections in patients with non-small-cell lung cancer treated with intensive induction chemotherapy
โœ Fuks, Joachim Z. ;Patel, Halesh ;Hornedo, Javier ;Van Echo, David A. ;Moody, Mar ๐Ÿ“‚ Article ๐Ÿ“… 1986 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 612 KB

The records of 65 consecutive patients with non-small-cell lung cancer (NSCLC) treated with intensive induction chemotherapy were reviewed to study the infectious complications during therapy and to analyze the relationship of the frequency of infections to various predisposing factors. A total of 4